Abstract
Cross-talk with TTEX CD8+ T cells mediated by the VEGFR2 axis induces aggressive properties in cancer stem cells to promote tumor progression.
©2023 American Association for Cancer Research.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
CD8-Positive T-Lymphocytes
-
Humans
-
Neoplasms*
-
Neoplastic Stem Cells
-
Programmed Cell Death 1 Receptor*
Substances
-
Programmed Cell Death 1 Receptor